High dose therapy and autologous hematopoietic stem cell transplantation in poor risk solid tumors of childhood

Haematologica

Volumn 85, Issue 11 SUPPL., 2000, Pages 66-70

  Dallorso, S ^a   Manzitti, C ^a   Morreale, G ^a   Faraci, M ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Autologous hematopoietic stem cell transplantation; Children; Solid tumors

Indexed keywords

ARTICLE; AUTOTRANSPLANTATION; BONE MARROW PURGING; BRAIN TUMOR; CHILDHOOD CANCER; EWING SARCOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; NEUROBLASTOMA; RECURRENT CANCER; RHABDOMYOSARCOMA; SOLID TUMOR; WHOLE BODY RADIATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASMS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0033710447     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Neuroblastoma: Biology and therapy
2. The Ewing Family of tumours: Ewing's sarcoma and primitive neuroectodermal tumors
3. Hematopoietic cell transplantation for neuroblastomas
4. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: Is cure possible in a small subgroup?
5. 1070 Myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions
6. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with mega-therapy and stem-cell transplantation: A report from the European Bone Marrow Transplantation Solid Tumor Registry
7. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: A multivariate analysis in 218 patients treated in a single institution
8. Hematopoietic stem cell transplantation in childhood: Report form the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)
9. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation and 13-cis-retinoic acid
10. Treatment of neuroblastoma Stage 4 with 131l meta-iodo-benzyl-guanidine, high dose chemotherapy and immunotherapy. A pilot study
11. Positive selection and transplantation of peripheral CD 34+ progenitor cells: Feasibility and purging eFFicacy in pediatric patients with neuroblastoma
12. Long-term results of CD 34+ cell transplantation in children with neuroblastoma
13. Ewing's sarcoma metastatic at diagnosis. Result and comparison of two intergroup Ewing's sarcoma studies
14. The impact of megatherapy (MGT) Followed by stem cell reinfusion (SCR) in Ewing tumor (ET) patients with residual disease
15. Impact of megatherapy in children with high-risk Ewing's turnouts in complete remission: A report from the EBMT Solid Tumour Registry
16. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma
17. Myeloablative therapy, stem cell rescue and gene transfer in advanced Ewing tumors
18. High dose melphalan with autologous stem cell rescue in metastatic rhabdomyosarcoma
19. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group
20. Brain tumours in children
21. High-dose busulfan and thiotepa with autologous bone marrow transpantation in childhood malignant brain tumors: A phase II study
22. High dose chemotherapy with autologous stem cell rescue in patients with recurrent and high risk pediatric brain tumors
23. High dose carboplatin, thiotepa and etoposide with autologous stemcell rescue For patients with recurrent medulloblastoma. Children's Cancer Group
24. High dose therapy and peripheral blood progenitor cells rescue as treatment of poor risk central nervous system tumours
25. G-CSF primed peripheral blood progenitor cells (PBPC) autotransplantation in stage IV neuroblastoma and poor risk solid tumors
26. Peripheral blood stem cell autografts for the treatment of children over 1 year old with stage IV neuroblastoma: A long-term follow-up
27. An analysis of engraftment kinetics as a function of the CD 34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy
28. Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: The number of CD 34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery
29. Factors that influence collection and engraftment of autologous peripheral -blood stem cells
30. Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors
31. Tandem high-dose therapy in rapid sequence for children with high risk neuroblastoma
32. Clonogenicity of circulating neuroblastoma cells: Implications regarding peripheral blood stem cell harvests
33. Detection of EWS chimeric transcripts by nested RT-PCR to allow reinfusion of uncontaminated peripheral blood stem cells in high risk Ewing's tumor in childhood